Overexpressing cell systems are a competitive option to primary adipocytes when predicting in vivo potency of dual GPR81/GPR109A agonists

Autor: Almquist, Joachim, Hovdal, Daniel, Ahlström, Christine, Fjellström, Ola, Gennemark, Peter, Sundqvist, Monika
Zdroj: In European Journal of Pharmaceutical Sciences 1 March 2018 114:155-165
Databáze: ScienceDirect